Dr. Šeila Selimović is Director of three extramural research programs at the National Institute of Biomedical Imaging and Bioengineering: Technologies for Tissue Chips, Engineered Tissues, and Biosensors and Physiological Detectors. Her programmatic activities also include a focus on biospecimen preservation, wearable sensors, paper diagnostic devices, and smart materials. In 2015, she was selected as one of the "50 Leaders of Tomorrow" from among hundreds of young biotech leaders in the Mid-Atlantic region. Prior to her current position, she was chosen by the American Association for the Advancement of Science (AAAS) to serve as a Science and Technology Policy Fellow at the U.S. Department of State, where she managed science diplomacy issues related to energy security, climate, and innovation. Before that, she was a Postdoctoral Research Fellow at Harvard Medical School and Brigham & Women’s Hospital in Boston, Massachusetts, working on heart and liver microphysiological systems. Dr. Selimović’s research has focused on the development of microfluidic platforms for applications in biophysics and biological engineering, including the physics of microscale flows, protein crystallization, colloidal suspensions, as well as rheology and microrheology. Dr. Selimović earned her Ph.D. and M. Sc. degrees in Physics from Brandeis University, with National Science Foundation support, and her B.A. degree from Wellesley College. She is a member of Sigma Xi and an author of over 60 research articles and editorials, 40+ national and international presentations, and editor of two books.